Previous 10 | Next 10 |
2023-10-19 10:32:58 ET What are the best penny stocks under $1 ? If you saw this headline, that’s probably a question you have heading into the second half of the week. As we’ve discussed in the past, your definition of “the best” compared to another trader...
2023-10-16 12:17:55 ET DENVER, Colo., Oct. 16, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Processa Pharmaceuticals Inc (NASDAQ: PCSA), Mereo BioPharma Group PLC (NASDAQ: MREO), Tempest Therape...
2023-10-16 09:56:56 ET DENVER, Colo., Oct. 16, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; LQR House Inc (NASDAQ: LQR), Better Therapeutics Inc (NASDAQ: BTTX), Mereo BioPharma Group PLC (NASDAQ: MREO)...
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, will be presenting at this month’s ThinkEquity Conference. The co...
HANOVER, MD, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety ...
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, will be presenting at the 25th annual H.C. Wainwright Global Investment ...
HANOVER, MD, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety...
Processa Pharmaceuticals (NASDAQ: PCSA) is a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer. The company today provided an interim analysis from its ongoing phase 1B t...
Interim analysis of Ph ase 1B data suggests Processa’s novel chemotherapy treatment could improve safety and efficacy in more patients by individualizing the dosing regimen for each patient HANOVER, MD, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Pro...
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for patients suffering from cancer, will be presenting at this month’s Sidoti & Co. Micro Cap Vir...
News, Short Squeeze, Breakout and More Instantly...
Processa Pharmaceuticals Inc. Company Name:
PCSA Stock Symbol:
OTCMKTS Market:
Processa Pharmaceuticals Inc. Website:
Processa Pharmaceuticals (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, has named a new chief financial officer. According to the announcement, Russell L. Skibsted has accepted the new...
HANOVER, Md., July 17, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, announces the appointment of Ru...
Processa (NASDAQ: PCSA) , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced positive efficacy results from the preliminary evaluation of its recently completed Phase 1b clinical trial. The...